Eli Lilly and Company(LLY)
Focus: Eli Lilly is a global pharmaceutical giant with $34.1B in FY2025 revenue, headquartered in Indianapolis and employing 43,000 people. The company specializes in biologics discovery across diabetes, oncology, neuroscience, and immunology.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
43,000
Open Jobs
0
About Eli Lilly and Company
AI assessmentNot HiringNo open roles listed right now. Follow Eli Lilly and Company to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Eli Lilly and Company's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
1 imminent
AXIRON
Hiring
Stable
Revenue
$34.1B
FY2025
Key Products
$7.4BStable
Peak
Company's revenue anchor at 59% of total revenue; dominant franchise but approaching maturity.
Help build intelligence for Eli Lilly and Company
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.